➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKinsey
Harvard Business School
Moodys
Medtronic

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Servier Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SERVIER, and what generic alternatives to SERVIER drugs are available?

SERVIER has one approved drug.

There are seven US patents protecting SERVIER drugs.

There are ninety-two patent family members on SERVIER drugs in thirty-five countries.

Summary for Servier
International Patents:92
US Patents:7
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Servier

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Servier TIBSOVO ivosidenib TABLET;ORAL 211192-001 Jul 20, 2018 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Servier TIBSOVO ivosidenib TABLET;ORAL 211192-001 Jul 20, 2018 RX Yes Yes 10,980,788 ⤷  Free Forever Trial ⤷  Free Forever Trial
Servier TIBSOVO ivosidenib TABLET;ORAL 211192-001 Jul 20, 2018 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Servier TIBSOVO ivosidenib TABLET;ORAL 211192-001 Jul 20, 2018 RX Yes Yes 10,449,184 ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Servier TIBSOVO ivosidenib TABLET;ORAL 211192-001 Jul 20, 2018 RX Yes Yes 9,474,779 ⤷  Free Forever Trial Y Y ⤷  Free Forever Trial
Servier TIBSOVO ivosidenib TABLET;ORAL 211192-001 Jul 20, 2018 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
Servier TIBSOVO ivosidenib TABLET;ORAL 211192-001 Jul 20, 2018 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Servier Drugs

Country Patent Number Estimated Expiration
South Korea 20160124914 ⤷  Free Forever Trial
Spain 2740424 ⤷  Free Forever Trial
Argentina 089768 ⤷  Free Forever Trial
South Korea 20140127255 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2015138839 ⤷  Free Forever Trial
Taiwan 201843136 ⤷  Free Forever Trial
Japan 6313714 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Medtronic
Express Scripts
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.